Mn Services Vermogensbeheer B.V. Raises Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Mn Services Vermogensbeheer B.V. increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.7% in the 4th quarter, HoldingsChannel reports. The firm owned 77,208 shares of the medical device company’s stock after acquiring an additional 1,300 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in Cooper Companies were worth $7,098,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the business. State Street Corp raised its holdings in shares of Cooper Companies by 1.2% during the third quarter. State Street Corp now owns 8,590,689 shares of the medical device company’s stock worth $947,897,000 after purchasing an additional 104,521 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Cooper Companies by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after purchasing an additional 573,908 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Cooper Companies by 1.0% during the third quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company’s stock worth $527,476,000 after purchasing an additional 48,559 shares during the last quarter. Victory Capital Management Inc. raised its holdings in shares of Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after purchasing an additional 737,726 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Cooper Companies by 11.9% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock worth $200,665,000 after purchasing an additional 194,118 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

COO has been the subject of a number of recent analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Citigroup cut their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a report on Friday, December 6th. Morgan Stanley cut their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Finally, Wells Fargo & Company lifted their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Stock Up 0.6 %

Shares of NASDAQ COO opened at $90.38 on Friday. The company’s 50-day simple moving average is $92.64 and its 200-day simple moving average is $99.48. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38. The firm has a market cap of $18.04 billion, a price-to-earnings ratio of 46.35, a price-to-earnings-growth ratio of 2.25 and a beta of 1.00. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Cooper Companies’s quarterly revenue was up 9.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.87 earnings per share. Equities analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.